| Year |
Citation |
Score |
| 2016 |
Chandra A, Sharma A, Calingasan NY, White JM, Shurubor Y, Yang XW, Beal MF, Johri A. Enhanced Mitochondrial Biogenesis Ameliorates Disease Phenotype in a Full-Length Mouse Model of Huntington's Disease. Human Molecular Genetics. PMID 27008868 DOI: 10.1093/Hmg/Ddw095 |
0.549 |
|
| 2014 |
Chandra A, Johri A, Beal MF. Prospects for neuroprotective therapies in prodromal Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 285-93. PMID 24573776 DOI: 10.1002/Mds.25835 |
0.512 |
|
| 2013 |
Johri A, Chandra A, Beal MF. PGC-1α, mitochondrial dysfunction, and Huntington's disease. Free Radical Biology & Medicine. 62: 37-46. PMID 23602910 DOI: 10.1016/J.Freeradbiomed.2013.04.016 |
0.538 |
|
| 2012 |
Johri A, Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. The Journal of Pharmacology and Experimental Therapeutics. 342: 619-30. PMID 22700435 DOI: 10.1124/Jpet.112.192138 |
0.533 |
|
| 2012 |
Chaturvedi RK, Hennessey T, Johri A, Tiwari SK, Mishra D, Agarwal S, Kim YS, Beal MF. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease. Human Molecular Genetics. 21: 3474-88. PMID 22589249 DOI: 10.1093/Hmg/Dds178 |
0.656 |
|
| 2012 |
Gollamudi S, Johri A, Calingasan NY, Yang L, Elemento O, Beal MF. Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease. Plos One. 7: e36191. PMID 22563483 DOI: 10.1371/Journal.Pone.0036191 |
0.583 |
|
| 2012 |
Johri A, Beal MF. Muscling in on PGC-1α for improved quality of life in ALS. Cell Metabolism. 15: 567-9. PMID 22560208 DOI: 10.1016/J.Cmet.2012.04.015 |
0.439 |
|
| 2012 |
Johri A, Beal MF. Antioxidants in Huntington's disease. Biochimica Et Biophysica Acta. 1822: 664-74. PMID 22138129 DOI: 10.1016/J.Bbadis.2011.11.014 |
0.553 |
|
| 2012 |
Johri A, Calingasan NY, Hennessey TM, Sharma A, Yang L, Wille E, Chandra A, Beal MF. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease. Human Molecular Genetics. 21: 1124-37. PMID 22095692 DOI: 10.1093/Hmg/Ddr541 |
0.665 |
|
| 2011 |
Johri A, Starkov AA, Chandra A, Hennessey T, Sharma A, Orobello S, Squitieri F, Yang L, Beal MF. Truncated peroxisome proliferator-activated receptor-γ coactivator 1α splice variant is severely altered in Huntington's disease. Neuro-Degenerative Diseases. 8: 496-503. PMID 21757867 DOI: 10.1159/000327910 |
0.666 |
|
| 2011 |
Johri A, Chaturvedi RK, Beal MF. Hugging tight in Huntington's. Nature Medicine. 17: 245-6. PMID 21383715 DOI: 10.1038/Nm0311-245 |
0.619 |
|
| 2011 |
Godau J, Lindig T, Schöls L, Berg D, Synofzik M, Frederiksen KS, Garde E, Skimminge A, Ryberg C, Rostrup E, Baaré WFC, Siebner HR, Hejl A, Leffers A, Fiedorowicz JG, ... ... Johri A, et al. Contents Vol. 8, 2011 Neurodegenerative Diseases. 8. DOI: 10.1159/000330927 |
0.567 |
|
| 2011 |
Johri A, Chaturvedi RK, Beal MF. Erratum: Corrigendum: Hugging tight in Huntington's Nature Medicine. 17: 514-514. DOI: 10.1038/Nm0411-514C |
0.544 |
|
| 2011 |
Johri A, Chaturvedi RK, Beal MF. Erratum: Hugging tight in Huntington's Nature Medicine. 17: 514-514. DOI: 10.1038/Nm0411-514B |
0.519 |
|
| 2010 |
Johri A, Beal MF. Hunting-ton for new proteases: MMPs as the new target? Neuron. 67: 171-3. PMID 20670824 DOI: 10.1016/J.Neuron.2010.07.011 |
0.446 |
|
| 2010 |
Chaturvedi RK, Calingasan NY, Yang L, Hennessey T, Johri A, Beal MF. Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation. Human Molecular Genetics. 19: 3190-205. PMID 20529956 DOI: 10.1093/Hmg/Ddq229 |
0.664 |
|
| Show low-probability matches. |